Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference61 articles.
1. Praziquantel: do we need another antischistosomal treatment?;Obe;Future Med Chem,2015
2. World Health Organisation: WHO urges increased access to praziquantel as schistosomiasis treatment coverage improves. Geneva: WHO; 2016.
3. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer);Olliaro;J Antimicrob Chemother,2014
4. Susceptibility or resistance of praziquantel in human schistosomiasis: a review;Wang;Parasitol Res,2012
5. The contribution of mass drug administration to global health: past, present and future;Webster;Phil Trans R Soc B,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of the Physicochemical Properties of Anti-Schistosomal Compounds to Identify Next-Generation Leads;ACS Medicinal Chemistry Letters;2024-04-25
2. Repurposing Know-how for Drug Development: Case Studies from the Swiss Tropical and Public Health Institute;CHIMIA;2023-09-20
3. Nuclear genome of Bulinus truncatus, an intermediate host of the carcinogenic human blood fluke Schistosoma haematobium;Nature Communications;2022-02-21
4. Improving translational power in antischistosomal drug discovery;Advances in Parasitology;2022
5. Drug associations as alternative and complementary therapy for neglected tropical diseases;Acta Tropica;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3